NEA Management Company, LLC - PARATEK PHARMACEUTICALS INC ownership

PARATEK PHARMACEUTICALS INC's ticker is PRTK and the CUSIP is 699374302. A total of 120 filers reported holding PARATEK PHARMACEUTICALS INC in Q2 2017. The put-call ratio across all filers is 0.41 and the average weighting 0.7%.

Quarter-by-quarter ownership
NEA Management Company, LLC ownership history of PARATEK PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2017$1,597,000
+25.3%
66,2450.0%0.06%
+31.8%
Q1 2017$1,275,000
+25.0%
66,2450.0%0.04%
+7.3%
Q4 2016$1,020,000
+18.3%
66,2450.0%0.04%
+5.1%
Q3 2016$862,000
-6.4%
66,2450.0%0.04%
-18.8%
Q2 2016$921,000
-51.4%
66,245
-47.0%
0.05%
-61.9%
Q1 2016$1,896,000
-20.0%
125,0040.0%0.13%
-16.6%
Q4 2015$2,371,000
-0.2%
125,0040.0%0.15%
-3.2%
Q3 2015$2,375,000
-47.0%
125,004
-28.1%
0.16%
-33.3%
Q2 2015$4,481,000
-17.6%
173,8920.0%0.23%
-4.9%
Q1 2015$5,436,000
-18.9%
173,892
-0.0%
0.25%
-24.3%
Q4 2014$6,704,000173,8940.32%
Other shareholders
PARATEK PHARMACEUTICALS INC shareholders Q2 2017
NameSharesValueWeighting ↓
AIGH Capital Management LLC 2,339,107$10,502,0003.20%
Telemetry Investments, L.L.C. 262,279$1,178,0001.52%
Bruce & Co., Inc. 1,443,312$6,480,0001.30%
Omega Fund Management, LLC 1,971,241$8,851,0001.25%
Worth Venture Partners, LLC 556,832$2,500,0001.24%
Abingworth LLP 1,041,131$4,654,0001.13%
1492 Capital Management LLC 491,033$2,205,0001.09%
CM Management, LLC 300,000$1,347,0001.02%
Trellus Management Company, LLC 295,000$1,325,0000.88%
GENERAL AMERICAN INVESTORS CO INC 1,306,919$5,868,0000.46%
View complete list of PARATEK PHARMACEUTICALS INC shareholders